Invention Grant
- Patent Title: Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
-
Application No.: US14652717Application Date: 2013-12-18
-
Publication No.: US09676812B2Publication Date: 2017-06-13
- Inventor: Douglas Covey , Albert Jean Robichaud
- Applicant: Washington University , Sage Therapeutics, Inc.
- Applicant Address: US MO St. Louis US MA Cambridge
- Assignee: Washington University,Sage Therapeutics, Inc.
- Current Assignee: Washington University,Sage Therapeutics, Inc.
- Current Assignee Address: US MO St. Louis US MA Cambridge
- Agency: Armstrong Teasdale LLP
- International Application: PCT/US2013/076214 WO 20131218
- International Announcement: WO2014/100228 WO 20140626
- Main IPC: C07J1/00
- IPC: C07J1/00 ; C07J5/00 ; C07J7/00 ; C07J21/00 ; C07J41/00 ; C07J51/00
Abstract:
The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.
Public/Granted literature
- US20170152282A9 NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME Public/Granted day:2017-06-01
Information query
